Amyris Inc (AMRS)

NASDAQ
14.54
-0.34(-2.28%)
After Hours
14.33
-0.21(-1.44%)
- Real-time Data
  • Volume:
    2,967,754
  • Bid/Ask:
    14.32/15.00
  • Day's Range:
    14.30 - 14.94

AMRS Overview

Prev. Close
14.88
Day's Range
14.3-14.94
Revenue
349.99M
Open
14.76
52 wk Range
1.88-23.34
EPS
-2.31
Volume
2,967,754
Market Cap
4.3B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
3,164,583
P/E Ratio
-
Beta
1.14
1-Year Change
220.26%
Shares Outstanding
295,555,034
Next Earnings Date
Aug 12, 2021
What is your sentiment on Amyris Inc?
or
Market is currently closed. Voting is open during market hours.

Amyris Inc News

Amyris Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellStrong SellSellBuy
Technical IndicatorsSellSellStrong SellSellStrong Buy
SummaryNeutralSellStrong SellSellStrong Buy

Amyris Inc Company Profile

Amyris Inc Company Profile

Industry
Chemicals
Sector
Materials
Employees
595

Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty markets through its consumer brands and as a supplier of sustainable and natural ingredients in Europe, the United States, Asia, Brazil, and internationally. It manufactures and sells products for the health and wellness, clean beauty, and flavor and fragrance markets. The company operates under the Amyris, Biofene, Biossance, Pipette, Purecane, and No Compromise trademarks. Amyris, Inc. has a collaboration agreement with the Infectious Disease Research Institute to advance a novel ribonucleic acid vaccine platform, including accelerating the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.

Read More
  • Buying opportunity in red sea of the market
    0
    • pre markit?
      0
      • when this chop is over .. this share will be a great opportunity.
        0
        • the market is trying to drive us crazy.!!!! this drop this is not explained ..
          0
          • An Astonishing Beat on revenue  and EPS this morning. EPS +.035 vs. forecast of -.02 and quarterly revenue of $177million vs. forecast of $73.36Mil. That's 507.62% increase in sales YOY
            0
            • I see big companies have profits the Q1 and to falling 20% .. and I'm scared for tomorrow.
              0
              • Stock Price ForecastThe 5 analysts offering 12-month price forecasts for Amyris Inc have a median target of 25.00, with a high estimate of 35.00 and a low estimate of 17.00. The median estimate represents a +30.82% increase from the last price of 19.11.https://money.cnn.com › quote › for...
                0
                • DJ DSM Buys Amyris's Flavor and Fragrance Business for Up to $300 Mln 13/31/2021, 2:19:00 AMListen to the newsAbout 1 min, 16 secondsBy Adria CalatayudKoninklijke DSM NV said Wednesday that it has agreed to acquire Amyris Inc.'s flavor and fragrance intermediates business for up to $300 million.The Dutch nutrition and materials company said it is paying $150 million upfront and further earnout payments estimated at between $100 million and $150 million.DSM in recent years acquired Amyris's Farnesene business as well as its Brotas biotechnology manufacturing facilities in Brazil. DSM and California-based Amyris will continue their research-and-development partnerships, the Dutch company said.DSM said the deal extends its offerings in aroma ingredients for the flavor-and-fragrance and cosmetics industries and strengthens its sustainability profile further as bio-based flavor and fragrance ingredients offer additional alternatives to chemistry-based products as well as botani
                  0
                  • The vultures are here
                    0
                    • Beat earnings expectations. Great news!
                      0
                      • WooHoo!
                        0
                        • Is it ever gooing to stop? IMO it should have dropped several times
                          1
                          • No, I'm sure that this company is going to be skyrocketed continuously. This has a lot of potential.
                            0
                        • The long term bottom is in.
                          0
                          • time to fall back to $3 level.
                            2
                            • ibio
                              0
                              • attention! AMRD may pop to $10 soon.
                                1
                                • Everyone, buy Aphria instead of this.
                                  0
                                  • No hype for this sadly. Buys cheap and stash and it may ****up later!
                                    1
                                    • very disappointed, should short this puppy!
                                      0
                                      • Can't believe this tanked even w/ record breaking reports.
                                        0
                                        • yes! break 5, next stop $6, and heading to 8....
                                          0
                                          • Dude, it's not gonna happen.
                                            0
                                        • the earnings will be big enough to push AMRS to $6, then $8....
                                          0
                                          • $5 is next!!!!
                                            0
                                            • the chart looks more uptrend coming.... I am in again...
                                              0
                                              • $8 here we go!
                                                0
                                                • hi Ray is 4.48 good price to get in?
                                                  0
                                                • Ben Tay  I'd recommend since positive earnings report is ahead!
                                                  0
                                              Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                              Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.